Epitomics
Epitomics operates as a product line within Abcam (Danaher Life Sciences), selling recombinant antibodies, ELISA kits, proteins, and biochemical reagents to academic and pharmaceutical researchers worldwide via a self-serve e-commerce platform with localized storefronts across the US, China, Japan, and Korea.
- Company typePublic
- Founded1998
- HeadquartersBurlingame, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Epitomics does
Epitomics, originally an independent rabbit monoclonal antibody specialist, was acquired by Abcam in 2012 and now operates as a product line within Abcam, which itself was acquired by Danaher Corporation in 2022. The epitomics.com domain redirects to Abcam's global website, through which the business sells a comprehensive life science reagents catalogue spanning primary antibodies (monoclonal, recombinant, polyclonal, conjugated, carrier-free, and application-specific panels), secondary antibodies, ELISA kits (SimpleStep, sandwich, competitive, and SimpleStep Ignite chemiluminescent), recombinant proteins, cytokines, peptides, cell lines, lysates, biochemical assays, and specialty chemicals.
The core technology platform is recombinant antibody engineering, with a catalogue of 37,000+ recombinant antibodies of which 4,900 are knock-out validated for high specificity, complemented by the proprietary SimpleStep single-wash ELISA format and the SimpleStep Ignite chemiluminescent variant (50x greater sensitivity, 35x broader measuring range). Trial-size 20 µL antibody formats support pre-purchase validation by researchers.
The business runs a product-led, self-serve e-commerce model targeting academic researchers, pharmaceutical and biotechnology R&D organizations, and disease-area specialists across neuroscience, oncology, immunology, metabolism, epigenetics, cardiovascular, and stem cell research. Revenue is generated through unit-priced catalog sales via localized storefronts in the US, China, Japan, and Korea, supported by extensive technical content, trial programs, and technical support from in-house scientists. The entity is positioned within the Danaher Life Sciences ecosystem alongside Beckman Coulter, Leica, Molecular Devices, SCIEX, Phenomenex, and IDT, enabling cross-platform workflow integration.
Epitomics firmographics
Firmographics- Name
- Epitomics
- Legal name
- Abcam Limited
- Website
- https://epitomics.com
- Company type
- Public
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Epitomics operates as a product line within Abcam (Danaher Life Sciences), selling recombinant antibodies, ELISA kits, proteins, and biochemical reagents to academic and pharmaceutical researchers worldwide via a self-serve e-commerce platform with localized storefronts across the US, China, Japan, and Korea.
- Ownership category
- akta.pro rank
Epitomics industry classification
Industry- Product category
- Life Science Reagents
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
- akta.pro secondary industries
- Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)
Keywords
Where Epitomics is headquartered
LocationHeadquarters
- HQ city
- Burlingame
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Epitomics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Antibody Product Sales: Sale of primary antibodies (monoclonal, recombinant, polyclonal), secondary antibodies (HRP conjugated, Alexa Fluor, fluorescent), conjugated antibodies, carrier-free antibodies, and specialty antibodies (tag antibodies, organelle markers, IHC antibodies, flow cytometry antibodies, Western blot antibodies, ChIP antibodies)
- ELISA Kits and Immunoassays: Sale of SimpleStep ELISA kits, sandwich ELISA kits, competitive ELISA kits, chemiluminescent SimpleStep Ignite ELISA, antibody pairs, protein standards, and antibody/cytokine arrays
- Proteins and Cell Lines: Sale of recombinant proteins, cytokines, growth factors, peptides, blocking peptides, cell lines, and lysates for research applications
- Biochemical and Cell-Based Assays: Sale of metabolism assays, cell health assays, enzyme activity assays, and related application reagents
- Biochemical Reagents: Sale of inhibitors, antagonists, agonists, and other specialty biochemical chemicals for research
- Application Reagents and Conjugation Kits: Sale of IHC and imaging reagents, Western blot reagents, ChIP and IP reagents, flow cytometry reagents, sample prep reagents, and antibody conjugation kits
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Standard product catalog with trial-size options |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels8 records
Epitomics product offering
Product offeringCore offering
Epitomics develops and sells a comprehensive catalog of recombinant antibodies, proteins, ELISA kits, biochemical assays, and cell-based reagents for life science research. Its core products are highly specific recombinant antibodies (including 4,900 knock-out validated products) sold alongside SimpleStep ELISA kits, recombinant proteins, cytokines, and biochemical reagents. The portfolio is sold globally through a self-serve e-commerce storefront to academic, pharmaceutical, and biotechnology researchers.
Product overview
Epitomics operates as a comprehensive life science reagents platform offering a broad portfolio of antibodies, ELISA kits, proteins, biochemical assays, and cell biology tools. The core offering centers on primary and secondary antibodies organized by application type (IHC, western blot, flow cytometry, ChIP, immunoprecipitation), complemented by SimpleStep ELISA kits across multiple formats (standard, chemiluminescent Ignite). Additional product lines include recombinant proteins, cytokines, cell lines, lysates, biochemical assays (metabolism, cell health, enzyme activity), and biochemicals (inhibitors, agonists, antagonists). The portfolio also features the MollAI intelligent assistant for product recommendations. Trial-size formats (20 µL) and conjugation kits extend the platform's flexibility for researchers.
Differentiator
Problem solved
Functional benefit
Products and services
- Primary Antibodies Comprehensive portfolio of highly cited primary antibodies including recombinant antibodies, monoclonal and recombinant antibodies, multiclonal and polyclonal antibodies, conjugated antibodies, carrier-free antibodies, antibody panels and cocktails, isotype controls, loading controls, tag antibodies, organelle markers, IHC/imaging antibodies, flow cytometry antibodies, western blot antibodies, and ChIP/immunoprecipitation antibodies. Sold to life science researchers for use in western blot, IHC, flow cytometry, ELISA, and immunoprecipitation.
- Secondary Antibodies Detection and visualization secondary antibodies including HRP conjugated, Alexa Fluor, fluorescent, and species-targeted secondaries for research applications.
- SimpleStep ELISA Kits Single-wash ELISA kits covering 1,000+ targets with simplified protocols, including the SimpleStep Ignite chemiluminescent variant delivering 50x greater sensitivity and up to 35x broader measuring range.
- Sandwich ELISA Kits Traditional sandwich ELISA kits for quantification of target proteins using matched antibody pairs.
- Competitive ELISA Kits Competitive ELISA kits for detection of small molecules, hormones, and antigens that compete with labeled analytes for antibody binding.
- Antibody Arrays and Cytokine Arrays Multiplex antibody array platforms enabling simultaneous detection of multiple analytes including cytokines in a single sample.
- ELISA Antibody Pairs and Protein Standards Matched antibody pairs and calibrated protein standards for development of custom ELISA assays.
- Recombinant Proteins High-quality extensively validated gene-edited recombinant proteins for research applications.
- Cytokines and Growth Factors Recombinant cytokines and growth factors for cell culture, assay development, and research applications.
- Cell Lines High-quality extensively validated gene-edited cell lines for accelerated research progress.
- Peptides and Blocking Peptides Synthetic peptides for antibody blocking experiments, epitope mapping, and antigen design.
- Lysates Cell and tissue lysates for use as positive controls and assay validation.
- Biochemical Assays Assay kits including metabolism assays, cell health assays, and enzyme activity assays for quantitative research measurements.
- Biochemicals Chemical compounds including enzyme inhibitors, antagonists, agonists, and other research chemicals for biochemical studies.
- Antibody Conjugation Kits Kits enabling researchers to conjugate antibodies with fluorophores, enzymes, or other labels for custom antibody labeling.
Quantifiable outcome
- 50x greater sensitivity with SimpleStep Ignite chemiluminescent ELISA compared to standard formats
- +3 more outcomes
Companies that use Epitomics
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Epitomics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Epitomics partnerships and signals
Strategic signalScale indicators13 records
Recent moves6 records
Expansion highlights5 records
Epitomics competitors and assessment
Company assessmentDirect peers
- Cell Signaling Technology: Direct peer in research-use antibodies and ELISA kits. Both companies sell validated antibodies for Western blot, IHC, flow cytometry, and ChIP, and compete head-to-head for academic and pharma R&D customers with premium validated catalogs.
- Bio-Techne: Direct peer across R&D Systems (proteins, antibodies, ELISA), Novus Biologicals (antibodies), and Tocris (biochemicals) brands. Highly comparable in recombinant proteins, cytokines, growth factors, and assay kits sold to life science researchers.
- Santa Cruz Biotechnology: Direct peer in research antibodies, with deep catalogs across monoclonal, polyclonal, and conjugated antibodies for Western blot, IHC, and flow cytometry. Historically competes on catalog breadth and price in academic research.
Broad incumbents
- Thermo Fisher Scientific (Invitrogen antibodies): Broader incumbent whose Invitrogen, Thermo Scientific, and Applied Biosystems brands sell research antibodies, ELISA kits, and recombinant proteins alongside instruments, consumables, and lab services. Overlaps in catalog reagent categories but competes from a much broader portfolio.
- Merck KGaA (MilliporeSigma life science): Broad incumbent selling antibodies, ELISA kits, proteins, and biochemicals through the MilliporeSigma and Sigma-Aldrich brands, alongside a much wider chemicals and lab products catalog. Direct overlap on antibody and ELISA product lines.
- BD Biosciences: Broad incumbent with a strong antibody portfolio especially for flow cytometry and immunology applications. Overlaps in primary antibodies, ELISA reagents, and flow cytometry consumables, with stronger clinical/diagnostic distribution reach.
- Revvity (formerly PerkinElmer Life Sciences): Broad incumbent selling antibodies, ELISA kits, and reagents alongside instruments and software for life science research. Competes across multiple of the company’s product categories as part of a wider portfolio.
Emerging players
- Proteintech Group: Emerging player that has scaled rapidly with a deep catalog of KO-validated antibodies and recombinant proteins, competing head-to-head with Abcam on specificity claims at typically lower price points.
- Atlas Antibodies: Emerging player focused on highly validated antibodies and the Human Protein Atlas, emphasizing tissue-specific IHC validation. Comparable on the specificity and reproducibility narrative that anchors the company’s value proposition.
- GeneTex: Emerging player in research antibodies with a focus on KO/KD validation and recombinant antibody development. Competes in Western blot, IHC, and ChIP-validated antibody categories against Abcam’s core catalog.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Epitomics social profiles
Digital presenceEpitomics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Epitomics leadership team
Management profileNumber of profiles
Epitomics funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Epitomics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Epitomics
What does Epitomics do?
Epitomics develops and sells a comprehensive catalog of recombinant antibodies, proteins, ELISA kits, biochemical assays, and cell-based reagents for life science research. Its core products are highly specific recombinant antibodies (including 4,900 knock-out validated products) sold alongside SimpleStep ELISA kits, recombinant proteins, cytokines, and biochemical reagents. The portfolio is sold globally through a self-serve e-commerce storefront to academic, pharmaceutical, and biotechnology researchers.
Is Epitomics a public or private company?
Epitomics is a public company. It is classified as corporate owned and is currently operating.
When was Epitomics founded?
Epitomics was founded in 1998. It employs 51 to 100 people.
Where is Epitomics based?
Epitomics is headquartered in Burlingame, United States, in the North America region.
How does Epitomics make money?
Six revenue lines are on record. Antibody Product Sales are the primary driver. The others are ELISA Kits and Immunoassays, proteins and Cell Lines, biochemical and Cell-Based Assays, biochemical Reagents and application Reagents and Conjugation Kits.
Who are Epitomics's main competitors?
Direct peers on record are Cell Signaling Technology, Bio-Techne and Santa Cruz Biotechnology. Broad incumbents are Thermo Fisher Scientific (Invitrogen antibodies), Merck KGaA (MilliporeSigma life science), BD Biosciences and Revvity (formerly PerkinElmer Life Sciences). Emerging players are Proteintech Group, Atlas Antibodies and GeneTex.
Does Epitomics have an API?
No public API is recorded for Epitomics.
What industry is Epitomics in?
Epitomics's product category is Life Science Reagents. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAAAIAB, Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering). Its NAICS code is 325414 and its SIC code is 2836.